Aria CV hopes to address pulmonary hypertension, a potentially devastating condition that currently has few treatments, with a unique balloon device that requires no power supply, battery, pump, or synchronization.
Pulmonary hypertension increases "afterload" on the right ventricle, which contributes to right-heart failure, but there are not many options to treat it, Aria CV CEO and co-founder John Scandurra told...